News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harbin Gloria Pharmaceuticals (002437.SZ) And Cumberland Pharmaceuticals (CPIX) In Translational R&D Partnership


5/6/2014 11:20:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 5, 2014 -- Harbin Gloria Pharma, a China injectable drugmaker, has joined Cumberland Pharma of Tennessee in Cumberland Emerging Technologies, a translational R&D effort. Both companies have made $1 million investments in CET, though Cumberland remains the majority owner. Gloria will have the right of first refusal on China rights to CET’s product candidates, which are discovered at Vanderbilt University in Nashville and other regional research centers. More details....

Stock Symbols: (SHE: 002437) (NSDQ: CPIX)

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES